Results 191 to 200 of about 29,988 (285)
Pharmacomicrobiomics is an emerging field due to important microbiome effects on pharmacokinetics and clinical outcomes. However, the application of this knowledge remains limited. Mycophenolic acid (MPA) is the primary active metabolite of the immunosuppressant, mycophenolate mofetil (MMF).
Abdelrahman Saqr +4 more
wiley +1 more source
Knowledge and Acceptability of Fecal Microbiota Transplantation Among Patients, Caregivers, and Health Care Providers in Ethiopia. [PDF]
Shackelford BB +9 more
europepmc +1 more source
Oral medications encounter gut commensal microbes that participate directly and indirectly in drug effects through metabolism, interactions with drug metabolites, or production of substrates that compete with drugs for drug‐metabolizing enzymes, consequently influencing drug pharmacokinetics.
Naomi Gronich +11 more
wiley +1 more source
Fecal microbiota transplantation in pigs: current status and future perspective. [PDF]
Rahman R, Marcolla CS, Willing BP.
europepmc +1 more source
Diarrhea after fecal microbiota transplantation for recurrent Clostridioides difficile infection [PDF]
Cole Krensky +2 more
openalex +1 more source
A Fast Path from Innovation to Safe and Effective Medicines
Consistent progress in medicines development has allowed both for de novo treatment options and for the refinement of existing products that improve effectiveness or reduce harm. Nonetheless, unmet medical needs persist, particularly in rare diseases, pediatrics and underserved populations.
Peter Arlett +11 more
wiley +1 more source
ABSTRACT Type 2 diabetes (T2D) is a major cause of morbidity in developed countries and involves insulin resistance, a failure to correctly respond to insulin. Numerous studies in rodent T2D models suggested that the short‐chain fatty acid butyrate, produced by gut microbiota species through fermentation of dietary fibers, improves T2D symptoms.
Elad Shapira +3 more
wiley +1 more source
Is Fecal Microbiota Transplantation Applicable for the Treatment of Irritable Bowel Syndrome? Time for Precision Medicine. [PDF]
Gweon TG.
europepmc +1 more source
Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson’s Disease: A Review of Inflammatory Markers and Potential Effects [PDF]
Karol Sadowski +4 more
openalex +1 more source

